Caggiano A O, Kraig R P
Committee on Neurobiology, University of Chicago, Illinois 60637, USA.
J Neurochem. 1999 Feb;72(2):565-75. doi: 10.1046/j.1471-4159.1999.0720565.x.
Prostaglandins (PGs) are potent modulators of brain function under normal and pathological conditions. The diverse effects of PGs are due to the various actions of specific receptor subtypes for these prostanoids. Recent work has shown that PGE2, while generally considered a proinflammatory molecule, reduces microglial activation and thus has an antiinflammatory effect on these cells. To gain further insight to the mechanisms by which PGE2 influences the activation of microglia, we investigated PGE receptor subtype, i.e., EP1, EP2, EP3, and EP4, expression and function in cultured rat microglia. RT-PCR showed the presence of the EP1 and EP2 but not EP3 and EP4 receptor subtypes. Sequencing confirmed their identity with previously published receptor subtypes. PGE2 and the EP1 agonist 17-phenyl trinor PGE2 but not the EP3 agonist sulprostone elicited reversible intracellular [Ca2+] increases in microglia as measured by fura-2. PGE2 and the EP2/EP4-specific agonists 11-deoxy-PGE1 and 19-hydroxy-PGE2 but not the EP4-selective agonist 1-hydroxy-PGE1 induced dose-dependent production of cyclic AMP (cAMP). Interleukin (IL)-1beta production, a marker of activated microglia, was also measured following lipopolysaccharide exposure in the presence or absence of the receptor subtype agonists. PGE2 and the EP2 agonists reduced IL-1beta production. IL-1beta production was unchanged by EP1, EP3, and EP4 agonists. The adenylyl cyclase activator forskolin and the cAMP analogue dibutyryl cAMP also reduced IL-1beta production. Thus, the inhibitory effects of PGE2 on microglia are mediated by the EP2 receptor subtype, and the signaling mechanism of this effect is likely via cAMP. These results show that the effects of PGE2 on microglia are receptor subtype-specific. Furthermore, they suggest that specific and selective manipulation of the effects of PGs on microglia and, as a result, brain function may be possible.
前列腺素(PGs)在正常和病理条件下都是脑功能的强效调节剂。PGs的多种作用归因于这些前列腺素特定受体亚型的不同作用。最近的研究表明,虽然PGE2通常被认为是一种促炎分子,但它能减少小胶质细胞的激活,因此对这些细胞具有抗炎作用。为了进一步深入了解PGE2影响小胶质细胞激活的机制,我们研究了PGE受体亚型,即EP1、EP2、EP3和EP4,在培养的大鼠小胶质细胞中的表达和功能。逆转录聚合酶链反应(RT-PCR)显示存在EP1和EP2受体亚型,但不存在EP3和EP4受体亚型。测序证实它们与先前发表的受体亚型一致。用fura-2测量发现,PGE2和EP1激动剂17-苯基三降PGE2可引起小胶质细胞内可逆的[Ca2+]增加,而EP3激动剂舒前列素则无此作用。PGE2以及EP2/EP4特异性激动剂11-脱氧-PGE1和19-羟基-PGE2可诱导剂量依赖性环磷酸腺苷(cAMP)的产生,而EP4选择性激动剂1-羟基-PGE1则无此作用。在有或无受体亚型激动剂存在的情况下,脂多糖暴露后还测量了白细胞介素(IL)-1β的产生,IL-1β是活化小胶质细胞的标志物。PGE2和EP2激动剂可减少IL-1β的产生。EP1、EP3和EP4激动剂对IL-1β的产生无影响。腺苷酸环化酶激活剂福斯高林和cAMP类似物二丁酰cAMP也可减少IL-1β的产生。因此,PGE2对小胶质细胞的抑制作用是由EP2受体亚型介导的,且这种作用的信号传导机制可能是通过cAMP。这些结果表明,PGE2对小胶质细胞的作用具有受体亚型特异性。此外还表明,对PGs对小胶质细胞进而对脑功能的作用进行特异性和选择性调控可能是可行的。